-transparent.png){kind=logo}
A 36-year-old man with ankylosing spondylitis, amyloidosis and chronic renal failure on maintenance hemodialysis developed severe hypoglycemia while being treated with propoxyphene. Upon discontinuation of the drug blood glucose levels returned to normal and hypoglycemia did not recur. Simultaneously with hypoglycemia, plasma glucagon and growth hormone levels were appropriately raised and serum insulin levels were adequately suppressed, thus ruling out hyperinsulinemia as the cause of hypoglycemia. A review of the literature disclosed four similar cases of propoxyphene-induced hypoglycemia, two of them with renal dysfunction. Propoxyphene should be remembered as a potential cause of hypoglycemia, particularly in patients with renal failure.
J Almirall, and
J Montoliu, and
A Torras, and
L Revert
January 2006,
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists,
J Almirall, and
J Montoliu, and
A Torras, and
L Revert
March 1977,
The Journal of the Florida Medical Association,
J Almirall, and
J Montoliu, and
A Torras, and
L Revert
April 1983,
Archives of internal medicine,
J Almirall, and
J Montoliu, and
A Torras, and
L Revert
June 1997,
The Annals of pharmacotherapy,
J Almirall, and
J Montoliu, and
A Torras, and
L Revert
January 1996,
Nephron,
J Almirall, and
J Montoliu, and
A Torras, and
L Revert
January 2003,
The International journal of artificial organs,
J Almirall, and
J Montoliu, and
A Torras, and
L Revert
January 1979,
Archives of internal medicine,
J Almirall, and
J Montoliu, and
A Torras, and
L Revert
August 2022,
Cureus,
J Almirall, and
J Montoliu, and
A Torras, and
L Revert
August 1973,
Israel journal of medical sciences,
J Almirall, and
J Montoliu, and
A Torras, and
L Revert
March 2003,
Diabetes research and clinical practice,
